NCT07066605View on ClinicalTrials.gov

The Effect of Dexmedetomidine on Agitation During Weaning From Mechanical Ventilation

NARecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 13, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Dexmedetomidine
Interventions
DRUG

Group A (Dexmedetomidine Group)

patients will receive dexmedetomidine infusion starting at 0.2 mcg/kg/hr.

DRUG

Group B (Control Group)

patients will receive standard ICU sedation protocol without dexmedetomidine (e.g., fentanyl)

Trial Locations (1)

Unknown

RECRUITING

Sohag University Hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT07066605 - The Effect of Dexmedetomidine on Agitation During Weaning From Mechanical Ventilation | Biotech Hunter | Biotech Hunter